Alexander Spira, MD, PhD, FACP, Virginia Cancer Specialists, US Oncology
Advertisement
Articles by Alexander Spira, MD, PhD, FACP, Virginia Cancer Specialists, US Oncology
Advertisement
Latest Updated Articles
ROS1-Rearranged NSCLC: Updates FromASCOPublished: August 19th 2021 | Updated:
Dr. Spira on the Impact of the PACIFIC-R Trial in Unresectable Stage III NSCLCPublished: September 24th 2021 | Updated:
RET-Fusions in NSCLC: Updates From ASCOPublished: August 12th 2021 | Updated:
NSCLC: FLAURA Trial ResultsPublished: July 8th 2021 | Updated:
ALK-Rearranged NSCLC: Updates From ASCOPublished: August 12th 2021 | Updated:
NSCLC: ADAURA Trial ResultsPublished: July 1st 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
4
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
5